CDTX vs VTRS · rev $1.3M vs rev $14.74B
Cidara Therapeutics Inc (CDTX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
CDTX currently screens at market cap $6.96B. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the CDTX and VTRS stock pages for the full models.
Not investment advice.